跳至主要内容
临床试验/NCT01474785
NCT01474785已完成1 期

RYGB Improves Metabolism by Interrupting the Gastric Adipose Tissue Axis

Vanderbilt University1 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2012年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
49
试验地点
1
主要终点
change in glucose disposal rate

研究概览

简要总结

The purpose of this study is to determine if interruption in gastric-adipose tissue axis signaling contributes to early improvements in oxidative stress, insulin sensitivity, and inflammation, and to determine if interruption of the stomach in RYGB results in reduction of plasma acylated ghrelin (AG) and in an altered acylated ghrelin:unacylated ghrelin (AG:UAG) ratio which may contribute to decreased oxidative stress and improved insulin sensitivity.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-65 years
  • BMI ≥ 35 kg/m^2
  • Scheduled for bariatric surgery
  • Considering bariatric surgery
  • Waiting for insurance approval for bariatric surgery
  • Currently not considering bariatric surgery, but otherwise eligible
  • Enrollment in medical weight loss program

排除标准

  • Smoking >7 cigarettes per day
  • Precious malabsorptive or restrictive intestinal surgery
  • Pregnant or breastfeeding
  • Recent history of neoplasia (5<years ago)
  • Malabsorptive syndromes
  • Inflammatory intestinal disease
  • Established organ disfunction
  • Allergy to acetaminophen

研究组 & 干预措施

RYGB

Experimental

Roux-en-Y gastric bypass surgery (RYGB) subjects to undergo hyperinsulinemic-euglycemic clamp with human ghrelin infusion pre-operatively and post-operatively.

干预措施: human ghrelin (Drug)

RYGB

Experimental

Roux-en-Y gastric bypass surgery (RYGB) subjects to undergo hyperinsulinemic-euglycemic clamp with human ghrelin infusion pre-operatively and post-operatively.

干预措施: Hyperinsulinemic/Euglycemic Clamp (Procedure)

VSG

Experimental

Vertical sleeve gastrectomy (VSG) subjects to undergo hyperinsulinemic-euglycemic clamp pre-operatively and post-operatively.

干预措施: Hyperinsulinemic/Euglycemic Clamp (Procedure)

Low Calorie Diet

Experimental

Subjects will receive very low calorie diet prescribed for RYGB patients and undergo hyperinsulinemic-euglycemic before and after diet.

干预措施: very low calorie diet (Other)

Low Calorie Diet

Experimental

Subjects will receive very low calorie diet prescribed for RYGB patients and undergo hyperinsulinemic-euglycemic before and after diet.

干预措施: Hyperinsulinemic/Euglycemic Clamp (Procedure)

结局指标

主要结局

change in glucose disposal rate

时间窗: baseline and 1 week

Glucose disposal rate is a sensitive laboratory procedure for determining how your body uses sugar (called insulin sensitivity).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Naji Abumrad

Professor of Surgery, Chairman Department of Surgery

Vanderbilt University

研究点 (1)

Loading locations...

相似试验